Drug pricing

News

Trump has finally delivered his healthcare proposals, but it seems the 'concept of a plan' promised for many years remains pretty much just that.

Market Access

Whatever people think of changes to the UK’s pricing deal, VPAG, judging the difference they make should include monitoring non-submissions to NICE.

News

AbbVie finally agrees a Most-Favoured Nation pricing deal with the US administration, with a $100 billion investment promise attached.

News

Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing deal with the Trump administration to avert tariffs.

News

Hospitals that challenged a US pilot of a new rebate model for medicines provided to low-income people have won another legal victory.

News

A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January.